Home>News Center>China
       
 

Roche licenses China firm to produce Tamiflu
(AP/Xinhua)
Updated: 2005-12-12 19:57

Swiss drugmaker Roche Holding AG said Monday it has chosen 12 potential partners for the production of Tamiflu and granted one sublicense for the antiviral drug to Shanghai Pharmaceutical.

Roche licenses China firm to produce Tamiflu
The Swiss pharmaceutical giant Roche said it had reached a sublicensing deal for production of its flagship anti-influenza drug Tamiflu in China with Shanghai Pharmaceutical group. [AFP]

Roche said it will grant Shanghai Pharmaceutical rights for the overall production of Tamiflu, also known as oseltamivir, for use in China.

"They are allowed to and they will produce the drug from the beginning to the end," said Piller.

Shanghai Pharmaceutical Group also announced the licensing agreement Monday at its website Monday, saying "Roche and Shanghai Pharmaceutical Group have signed the first sub-licensing agreement for the overall production of oseltamivir for pandemic use in China."

An official with the Shanghai Pharmaceutical Group said its products will not bear the name of "Tamiflu", but the ingredients and quality will be the same with Tamiflu produced by Roche.

He said the group aims to form a monthly production capacity of 200,000 treatments in six months in the first step.

According to the official, the group made the request to produce and sell Tamiflu under a sub-license in November.

The announcement said Roche is also "in negotiations for local partnerships in other countries."

Roche said it compiled the shortlist of potential partners, which it did not identify, after evaluating around 200 applicants interested in helping with certain steps in the manufacture of Tamiflu. It didn't say how many it would finally choose.

Roche said it would mainly use the partners, which include major pharmaceutical makers, large generic manufacturers and specialty chemical producers, as backups, to meet specific regional needs and to prepare for any large additional government orders in the future.

"We are now also in the position to have a backup supply in case of an emergency," said David Reddy, who heads Roche's influenza pandemic task force.

   上一頁 1 2 下一頁  



Fire kills 5 in Northeast China
Aerobatics show in Hunan
Final rehearsal
  Today's Top News     Top China News
 

Australia, US, Japan praise China for Asia engagement

 

   
 

Banker: China doing its best on flexible yuan

 

   
 

Hopes high for oil pipeline deal

 

   
 

Possibilities of bird flu outbreaks reduced

 

   
 

Milosevic buried after emotional farewell

 

   
 

China considers trade contracts in India

 

   
  EU likely to impose tax on imports of Chinese shoes
   
  Bankers confident about future growth
   
  Curtain to be raised on Year of Russia
   
  Coal output set to reach record high of 2.5b tons
   
  WTO: China should reconsider currency plan
   
  China: Military buildup 'transparent'
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Roche sets up R&D centre in Shanghai
   
Roche to expand presence in China
   
China human bird flu vaccine at least a year away
   
China: Bird flu virus in humans mutating
   
Study: Vaccine can stop poultry from spreading bird flu to each other
   
China confirms fifth human case of bird flu
   
Human case confirmed in Liaoning
   
Roche in talks for Tamiflu production in China
Manufacturers, Exporters, Wholesalers - Global trade starts here.
Advertisement
         
主站蜘蛛池模板: 欧美黑人又粗又大久久久| 久久精品道一区二区三区| 337p日本欧洲亚洲大胆色噜噜| 欧美大尺度电影| 厨房切底征服麻麻| 999久久久免费精品播放| 欧美jizz18欧美| 免费污污视频在线观看| 高清欧美一区二区免费影视| 成年私人影院免费视频网站| 亚洲午夜电影一区二区三区| 精品一区精品二区制服| 国产国产精品人在线视| 2022年亚洲午夜一区二区福利| 尤物在线影院点击进入| 伊人久久大香线蕉综合爱婷婷| 91精品啪在线观看国产18| 极品精品国产超清自在线观看| 免费av一区二区三区| 亚洲视频一区二区三区四区| 女人16一毛片| 久9久9精品视频在线观看| 欧美e片成人在线播放乱妇| 亚洲色大成网站WWW国产| 美国特级成人毛片| 国产国语videosex| 福利姬在线精品观看| 扒开双腿猛进入免费观看美女| 亚洲一区爱区精品无码| 熟女性饥渴一区二区三区| 四虎成人免费网站在线| 黑人巨茎大战俄罗斯美女| 快点cao我要被cao烂了男女| 久久精品国产99国产精偷| 欧美日本一本线在线观看| 伊人久久大香线蕉综合热线| 美女把屁股扒开让男人桶视频| 国产麻豆成91| 久久久久亚洲av无码专区| 欧美一级高清黄图片| 又色又爽又黄的视频女女高清|